Endocrine-related cancers arise from glands that produce hormones, such as the thyroid, adrenal, and pituitary glands. These cancers often exhibit unique characteristics due to the role hormones play in cell growth and regulation. Research in this field aims to understand the intricate interplay between hormones and cancer development, seeking targeted treatments that disrupt cancerous cell growth while sparing healthy tissue. Advances in molecular biology have unveiled specific genetic mutations driving endocrine-related cancers, paving the way for personalized therapies tailored to individual patients. Additionally, emerging immunotherapy approaches hold promise in bolstering the body's immune response against these cancers. Through interdisciplinary collaboration and innovative technologies, scientists strive to improve early detection methods and develop more effective treatment strategies, ultimately enhancing outcomes for patients battling endocrine-related cancers.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States